BlackRock Investment Management’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $334K | Hold |
1,236
| – | – | ﹤0.01% | 3123 |
|
|
2016
Q3 | $489K | Sell |
1,236
-1
| -0.1% | -$396 | ﹤0.01% | 3040 |
|
|
2016
Q2 | $429K | Buy |
1,237
+405
| +49% | +$140K | ﹤0.01% | 3117 |
|
|
2016
Q1 | $692K | Buy |
832
+14
| +2% | +$11.6K | ﹤0.01% | 2729 |
|
|
2015
Q4 | $856K | Buy |
818
+2
| +0.2% | +$2.09K | ﹤0.01% | 2710 |
|
|
2015
Q3 | $641K | Sell |
816
-20
| -2% | -$15.7K | ﹤0.01% | 2907 |
|
|
2015
Q2 | $1.1M | Buy |
836
+465
| +125% | +$611K | ﹤0.01% | 2693 |
|
|
2015
Q1 | $755K | Buy |
371
+7
| +2% | +$14.2K | ﹤0.01% | 2707 |
|
|
2014
Q4 | $700K | Buy |
364
+28
| +8% | +$53.8K | ﹤0.01% | 2792 |
|
|
2014
Q3 | $275K | Buy |
336
+15
| +5% | +$12.3K | ﹤0.01% | 3181 |
|
|
2014
Q2 | $310K | Buy |
321
+85
| +36% | +$82.1K | ﹤0.01% | 3174 |
|
|
2014
Q1 | $255K | Buy |
236
+11
| +5% | +$11.9K | ﹤0.01% | 3184 |
|
|
2013
Q4 | $200K | Sell |
225
-4
| -2% | -$3.56K | ﹤0.01% | 3202 |
|
|
2013
Q3 | $259K | Buy |
229
+22
| +11% | +$24.9K | ﹤0.01% | 3132 |
|
|
2013
Q2 | $244K | Buy |
+207
| New | +$244K | ﹤0.01% | 3123 |
|